Showing 1 - 10 of 400
Background: Health care expenditures (HCE) are known to steepen with increasing age, but the contributions of biological age, morbidity, or proximity to death as cost drivers are debated. Age-associated HCE growth can be studied across two dimensions: within fixed groups of persons with the same...
Persistent link: https://www.econbiz.de/10011982683
Benefit-cost analyses in public health typically calculate the benefits of mortality reduction interventions by multiplying the Value of a Statistical Life (VSL) and the expected decrease in fatalities. This procedure approximates the benefits of small mortality changes but is inaccurate for...
Persistent link: https://www.econbiz.de/10014353332
In response to the COVID-19 outbreak, among other previous "non-pharmaceutical interventions'', on March 22, 2020 the Italian Government imposed an economic lockdown and ordered the closing of all non-essential economic activities. This paper estimates the causal effect of this measure on...
Persistent link: https://www.econbiz.de/10012823599
Once a humble, beloved, charity-based arm of the healthcare industry, hospice is now a multi-billion dollar industry, funded almost exclusively by Medicare, run by for-profit corporations answering to private equity investors and Wall Street, and more and more frequently plagued by fraud and...
Persistent link: https://www.econbiz.de/10012996828
In response to the Covid-19 outbreak, among other previous "non-pharmaceutical interventions", on March 22, 2020 the Italian Government imposed an economic lockdown and ordered the closing of all non-essential economic activities. This paper estimates the causal effect of this measure on...
Persistent link: https://www.econbiz.de/10012291890
This paper examines the relationship between public financial management (PFM), the financing of health interventions, and health outcomes. Specifically, the paper econometrically tests whether the effect of PFM on under-five (U5) mortality depends on the relevance of public sector health...
Persistent link: https://www.econbiz.de/10011992296
This paper analyzes the relationship between three dimensions (economic, social, and political) of globalization and life expectancy using a panel of 92 countries covering the 1970-2005 period. Using different estimation techniques and sample groupings, we find that economic globalization has a...
Persistent link: https://www.econbiz.de/10014151072
In this study we report an attempt to measure the value adult Swedes impute to an increased survival probability at high ages. A rating scale between the worst possible quality of life (=3D1) and the best possible quality of life (=3D10) is used to indicate the quality of life a person expects...
Persistent link: https://www.econbiz.de/10014073535
The value of risks to life as measured by the risk-money trade-off plays a fundamental role in economic analyses of health and safety risks and serves as the principal benefit measure for government risk regulation policies. The hedonic models that have been employed to generate empirical...
Persistent link: https://www.econbiz.de/10014025525
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...
Persistent link: https://www.econbiz.de/10013069689